Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
59%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
OZEM
20
HOLDINGS
62%
ALSO IN THNR
THNR
18
HOLDINGS
72%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.7% | 14.1% | 14.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 12.9% | 14.2% | 12.9% |
|
PFIZER INC | 6.4% | 4.6% | 4.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.2% | 5.2% | 4.2% |
 |
CHINA PHARMACEUTICAL GROUP | 4.3% | 3.8% | 3.8% |
OZEM Overweight Relative to THNR
|
ELI LILLY & CO | 4.7% |
|
MBX BIOSCIENCES INC | 2.9% |
|
VIKING THERAPEUTICS, INC. | 2.5% |
 |
HANMI PHARM CO LTD | 2.4% |
|
THE UNITED LABORATORIES INTE | 2.3% |
 |
ASCLETIS PHARMA, INC. | 2.3% |
|
BIOHAVEN PHARMACEUTICAL HOLDING COMP | 2.3% |
|
ZEALAND PHARMA A/S | 2.0% |
|
PFIZER INC | 1.7% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.7% |
OZEM Underweight Relative to THNR
|
ARROWHEAD PHARMACEUTICALS, INC. | -6.5% |
|
MERCK & CO. INC. | -4.9% |
|
ABBVIE INC | -4.8% |
|
REGENERON PHARMACEUTICALS | -2.9% |
|
SHIONOGI & CO LTD | -2.8% |
|
AMGEN INC | -2.4% |
|
SCHOLAR ROCK HOLDING CORP. | -2.3% |
|
NOVO-NORDISK A/S-SPONS ADR | -1.3% |
 |
ASTRAZENECA PLC | -1.3% |
|
JIANGSU HENGRUI PHARMACEUT-H | -1.0% |